Advances recognized by science’s most lucrative awards include high-energy physics experiments and groundbreaking weight-loss ...
The Trump administration rejected a proposed rule to allow Medicare to cover blockbuster obesity drugs for weight loss alone ...
Rhythm Pharmaceuticals said on Monday that its experimental drug to treat a rare obesity disorder met the main goal in a late-stage trial.
This is a major source of cardiovascular morbidity and mortality. We have never been able to treat lipoprotein(a) until now.” ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback